Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease has improved. Several new and effective antiviral agents …

Chronic hepatitis B virus (HBV) infection has a complicated course. Three phases are
identified: an immune tolerant phase with high HBV DNA and normal alanine …

Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease is continuously improving. New data have become …

This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …

These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …

Chronic hepatitis B is caused by persistent infection with the hepatitis B virus (HBV), a
unique DNA virus that replicates through an RNA intermediate produced from a stable …

Most viral diseases, with the exception of those caused by human immunodeficiency virus,
are self-limited illnesses that do not require specific antiviral therapy. The currently available …

More than 360 million persons worldwide (6% of the world population) are chronically
infected by the hepatitis B virus (HBV). Although the incidence of HBV infection has …

Hepatitis B virus (HBV) is the leading cause of chronic liver disease and liver-related death
worldwide, with the majority of these cases occurring in areas of Africa and Asia where HBV …

Persons at high risk for human immunodeficiency virus (HIV) infection are also likely to be at
risk for other infectious pathogens, including hepatitis B virus (HBV) or hepatitis C virus …